AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 179 filers reported holding AXSOME THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $19,775,901 | +72.9% | 256,397 | 0.0% | 0.01% | +66.7% |
| Q3 2022 | $11,440,434 | +28.2% | 256,397 | +10.0% | 0.00% | +50.0% |
| Q2 2022 | $8,925,662 | +21.6% | 233,046 | +31.5% | 0.00% | 0.0% |
| Q1 2022 | $7,337,619 | +1.0% | 177,280 | -7.8% | 0.00% | +100.0% |
| Q4 2021 | $7,266,000 | +14.6% | 192,329 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $6,339,000 | +51.0% | 192,329 | +209.1% | 0.00% | 0.0% |
| Q2 2021 | $4,198,000 | -64.3% | 62,223 | -70.1% | 0.00% | -66.7% |
| Q1 2021 | $11,773,000 | -47.4% | 207,922 | -24.4% | 0.00% | -40.0% |
| Q4 2020 | $22,397,000 | +10.7% | 274,909 | -3.2% | 0.01% | 0.0% |
| Q3 2020 | $20,225,000 | -39.5% | 283,855 | -30.1% | 0.01% | -50.0% |
| Q2 2020 | $33,422,000 | +84.2% | 406,198 | +31.7% | 0.01% | +66.7% |
| Q1 2020 | $18,143,000 | – | 308,392 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 758,794 | $53,032,113 | 65.14% |
| Fairmount Funds Management LLC | 2,341,238 | $163,629,124 | 19.69% |
| Ally Bridge Group (NY) LLC | 110,600 | $7,729,834 | 9.07% |
| RTW INVESTMENTS, LP | 4,489,596 | $313,777,864 | 6.62% |
| SVB FINANCIAL GROUP | 33,849 | $2,365,707 | 4.45% |
| BVF INC/IL | 2,131,100 | $148,942,579 | 4.02% |
| Altium Capital Management LP | 92,000 | $6,429,880 | 3.35% |
| Tri Locum Partners LP | 142,510 | $9,960,024 | 3.18% |
| TANG CAPITAL MANAGEMENT LLC | 320,000 | $22,364,800 | 3.16% |
| Deep Track Capital, LP | 1,140,745 | $79,726,668 | 3.08% |